205 related articles for article (PubMed ID: 17553900)
1. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
Zhou Z; Flesken-Nikitin A; Nikitin AY
Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
[TBL] [Abstract][Full Text] [Related]
2. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
Zhou Z; Flesken-Nikitin A; Corney DC; Wang W; Goodrich DW; Roy-Burman P; Nikitin AY
Cancer Res; 2006 Aug; 66(16):7889-98. PubMed ID: 16912162
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.
Rubio R; García-Castro J; Gutiérrez-Aranda I; Paramio J; Santos M; Catalina P; Leone PE; Menendez P; Rodríguez R
Cancer Res; 2010 May; 70(10):4185-94. PubMed ID: 20442289
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
6. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi N; Shimada K; Nakamura M; Ishida E; Ota I; Tanaka N; Fujimoto K
Clin Cancer Res; 2008 Jul; 14(14):4408-16. PubMed ID: 18628455
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
8. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
Vooijs M; te Riele H; van der Valk M; Berns A
Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
[TBL] [Abstract][Full Text] [Related]
9. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
10. Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis.
Goto K; Salm SN; Coetzee S; Xiong X; Burger PE; Shapiro E; Lepor H; Moscatelli D; Wilson EL
Stem Cells; 2006 Aug; 24(8):1859-68. PubMed ID: 16644920
[TBL] [Abstract][Full Text] [Related]
11. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
12. Conditional deletion of Rb causes early stage prostate cancer.
Maddison LA; Sutherland BW; Barrios RJ; Greenberg NM
Cancer Res; 2004 Sep; 64(17):6018-25. PubMed ID: 15342382
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
15. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells.
Xin L; Lukacs RU; Lawson DA; Cheng D; Witte ON
Stem Cells; 2007 Nov; 25(11):2760-9. PubMed ID: 17641240
[TBL] [Abstract][Full Text] [Related]
16. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
Miki J; Rhim JS
Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
[TBL] [Abstract][Full Text] [Related]
17. Aging of the prostate epithelial stem/progenitor cell.
Zenzmaier C; Untergasser G; Berger P
Exp Gerontol; 2008 Nov; 43(11):981-5. PubMed ID: 18639623
[TBL] [Abstract][Full Text] [Related]
18. Stem cells in prostate and prostate cancer development.
Lam JS; Reiter RE
Urol Oncol; 2006; 24(2):131-40. PubMed ID: 16520277
[TBL] [Abstract][Full Text] [Related]
19. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
20. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]